Found: 12
Select item for more details and to access through your institution.
A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 9, p. 826, doi. 10.3390/v11090826
- By:
- Publication type:
- Article
Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology.
- Published in:
- Animal Models & Experimental Medicine, 2024, v. 7, n. 3, p. 259, doi. 10.1002/ame2.12440
- By:
- Publication type:
- Article
Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor.
- Published in:
- Virologica Sinica (16740769), 2023, v. 38, n. 6, p. 931, doi. 10.1016/j.virs.2023.09.003
- By:
- Publication type:
- Article
Revisiting influenza A virus life cycle from a perspective of genome balance.
- Published in:
- Virologica Sinica (16740769), 2023, v. 38, n. 2, p. 1, doi. 10.1016/j.virs.2022.10.005
- By:
- Publication type:
- Article
Revisiting influenza A virus life cycle from a perspective of genome balance.
- Published in:
- Virologica Sinica (16740769), 2023, v. 38, n. 1, p. 1, doi. 10.1016/j.virs.2022.10.005
- By:
- Publication type:
- Article
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00564-x
- By:
- Publication type:
- Article
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00564-x
- By:
- Publication type:
- Article
Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 8, p. 1, doi. 10.1371/journal.ppat.1010756
- By:
- Publication type:
- Article
Development of a virus‐based affinity ultrafiltration method for screening virus‐surface‐protein‐targeted compounds from complex matrixes: Herbal medicines as a case study.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 3, p. 1, doi. 10.1002/jmv.29517
- By:
- Publication type:
- Article
Licochalcone A plays dual antiviral roles by inhibiting RSV and protecting against host damage.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 8, p. 1, doi. 10.1002/jmv.29059
- By:
- Publication type:
- Article
Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 3, p. 1, doi. 10.1002/jmv.28609
- By:
- Publication type:
- Article
Punicalagin is a neuraminidase inhibitor of influenza viruses.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 6, p. 3465, doi. 10.1002/jmv.26449
- By:
- Publication type:
- Article